CIA
PFE icon

Cohen Investment Advisors’s Pfizer PFE Stock Holding History

Cohen Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99M Buy
124,325
+2,335
+2% +$61.1K 1.34% 34
2026
Q1 		$3.43M Buy
121,990
+3,030
+3% +$80.7K 1.63% 30
2025
Q4 		$2.96M Buy
118,960
+5,185
+5% +$131K 1.36% 37
2025
Q3 		$2.9M Buy
113,775
+10,285
+10% +$254K 1.41% 36
2025
Q2 		$2.51M Buy
103,490
+14,984
+17% +$349K 1.31% 39
2025
Q1 		$2.24M Buy
88,506
+10,097
+13% +$264K 1.3% 37
2024
Q4 		$2.08M Buy
78,409
+3,343
+4% +$90.7K 1.25% 38
2024
Q3 		$2.17M Buy
75,066
+12,342
+20% +$360K 1.33% 37
2024
Q2 		$2.08M Sell
62,724
-7,198
-10% -$198K 1.67% 26
2024
Q1 		$1.94M Buy
69,922
+8,467
+14% +$235K 1.26% 40
2023
Q4 		$1.77M Sell
61,455
-1,269
-2% -$38.4K 1.3% 38
2023
Q3 		$2.08M Buy
62,724
+6,244
+11% +$221K 1.67% 26
2023
Q2 		$2.07M Sell
56,480
-3,596
-6% -$140K 1.67% 27
2023
Q1 		$2.45M Buy
60,076
+495
+0.8% +$21.4K 1.94% 20
2022
Q4 		$3.05M Buy
59,581
+554
+0.9% +$26.6K 2.54% 8
2022
Q3 		$2.58M Sell
59,027
-567
-1% -$27.6K 2.37% 10
2022
Q2 		$3.13M Buy
59,594
+62
+0.1% +$3.16K 2.68% 6
2022
Q1 		$3.08M Sell
59,532
-282
-0.5% -$14.6K 2.29% 10
2021
Q4 		$3.53M Sell
59,814
-751
-1% -$37.2K 2.52% 7
2021
Q3 		$2.6M Buy
60,565
+144
+0.2% +$6.38K 2% 19
2021
Q2 		$2.37M Sell
60,421
-917
-1% -$35.7K 1.84% 22
2021
Q1 		$2.24M Buy
61,338
+4,119
+7% +$146K 1.82% 27
2020
Q4 		$2.11M Buy
+57,219
New +$2.1M 1.9% 23

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cohen Investment Advisors's PFE Position: Q2 2026 in Review

Cohen Investment Advisors increased its Pfizer (PFE) stake by 1.9% in Q2 2026, buying an estimated $61.1K and bringing the position to 124,325 shares worth $2.99M. The position accounts for 1.34% of the portfolio, ranked #34.

Cohen Investment Advisors first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.53M in Q4 2021. 2,829 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cohen Investment Advisors held 124,325 shares of Pfizer worth $2.99M as of Q2 2026.
  • Cohen Investment Advisors bought 2,335 Pfizer shares in Q2 2026, an estimated $61.1K.
  • Pfizer made up 1.34% of Cohen Investment Advisors's portfolio in Q2 2026, its #34 holding.
  • Cohen Investment Advisors first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Cohen Investment Advisors's Pfizer position peaked at $3.53M in Q4 2021.
  • 2,829 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cohen Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.